Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Six-Month, Randomized, Open-Label, Parallel-group Comparison of SAR342434 to Humalog® in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine, With a 6-month Safety Extension Period

NCT02273180 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT02273180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02273180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Six-Month, Randomized, Open-Label, Parallel-group Comparison of SAR342434 to Humalog® in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine, With a 6-month Safety Extension Period
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2014
Completion date
July 31, 2016
Enrollment
507 (actual)
Sites
89

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus